|Day Low/High||46.13 / 47.44|
|52 Wk Low/High||20.73 / 59.00|
Bill Ackman's Herbalife short could take a major hit after Robert Chapman's recent move.
There is simply no reason to enter Herbalife. Pershing Square's analysis of Herbalife is the most remarkable piece of investment analysis I have ever seen. Simply astonishing. And kudos to Pershing Square for making all of it public - not just the 3...
I bailed on this trade a little too early. By Tim Collins The Herbalife (HLF) Dec. 21 $35-Dec. 21 $32.50 long 1 by short 2 ratio put spread picked up yesterday has increased nicely, trading around a buck now. I bailed on this one and a bit too early...
Management shakeups, hyped takeovers and loud proxy fights are flashing signals to stay away.
Halfway out. By Tim Collins Out of half the ratio put spread lottery tickets on Herbalife (HLF) for $0.45.
Ackman stated that any profits from his Herbalife short are for charity. By Tim Collins Bill Ackman has said all, if any, profits from his Herbalife (HLF) short will go to charity. Therefore, he implies if you buy Herbalife, you have charities. Alri...
We've bounced off of long-term support, but Ackman has plenty of power. By Tim Collins It looks to me as though Herbalife (HLF) has started to bottom for now, especially based on the weekly chart. Herbalife (HLF) Source: StockCharts.com View Chart »...
Tupperware is a pristine brand that resonates with the most prestigious customer in the world.
Based on the speed and trajectory of today's move, our wait-and-see mindset will continue.
Instead, use your edge as an individual investor -- and you could handily come out on top.
Mike MacDonald, CEO of Medifast, says the company's new franchise strategy is propelling its stock and recently approved weight loss pills are not a threat.
COH and HLF are looking for earnings redemption. I am also keeping an eye on WTI.
Contributor Ken Shreve takes a look at upcoming economic data plus some key earnings reports for the week of July 30.
Stephen Weiss, author of The Big Win, says investors have a lot to learn from these legendary fund managers.
There is no need to play direction right now. Knee-jerk analysis of the non-farm payroll report. Another headline you will see for the next few hours. This touches upon my opening this morning. Rather than taking a little time to read through the NF...
Here is this week's roundup of the dumbest actions on Wall Street.
MasterCard will be a tell on the consumer, and Kenexa and Garmin are getting playable.
The shares tumble after management's weak guidance. Herbalife (HLF) takes a quick fall after reporting in-line EPS but weak guidance.
Contributor Ken Shreve takes a look at the economic data and earnings reports slated for the coming week.
To prepare for this kind of selling storm, buy deep-in-the-money calls.
This market needs to catch its breath -- and this will probably happen sooner rather than later.
Given the favorable macro trends and some sound management decisions, GNC is well worth considering.